| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 14 Nov 2025 | 7 Nov 2025 |
| Boston Bio Systems Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve Unaudited Financial Results of the Company for the quarter and half year ended September 30 2025 under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. Outcome of Board Meeting pursuant to Regulation 30 of SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015 held today i.e. 14th November, 2025. Unaudited Financial Results of the company for the quarter and half year ended on 30th September, 2025. (As Per BSE Announcement Dated on:14.11.2025) | ||
| Board Meeting | 4 Sep 2025 | 4 Sep 2025 |
| Please find enclosed the outcome of the Board Meeting | ||
| Board Meeting | 14 Aug 2025 | 8 Aug 2025 |
| Boston Bio Systems Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 inter alia to consider and approve Intimation for board meeting to be held on 14th August 2025 for considering the unaudited financial results for the quarter ended 30th June 2025. Please Find Enclosed Herewith Outcome of the Board Meeting For Your Records for the Quarter Ended 30th June 2025 (As Per BSE Announcement Dated on: 14.08.2025) | ||
| Board Meeting | 8 Jul 2025 | 8 Jul 2025 |
| Please find enclosed the Outcome of Board Meeting held on 08th July, 2025 of Boston Bio Systems Limited | ||
| Board Meeting | 30 May 2025 | 21 May 2025 |
| Boston Bio Systems Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve Audited Financial Results of the Company for the quarter and year ended on 31st March 2025. Please Find the Enclosed herewith Audited Results for FY 31 march 2025 Please Find Enclosed Herewith Outcome of the Board Meeting For year ended 31st March, 2025 (As per BSE Announcement Dated on 30/05/2025) | ||
| Board Meeting | 12 May 2025 | 12 May 2025 |
| Please find enclosed herewith Outcome of the board meeting for your information. | ||
| Board Meeting | 14 Feb 2025 | 10 Feb 2025 |
| Boston Bio Systems Ltd.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve To consider and approve unaudited financial results for the quarter and nine months ended 31st December 2024 Outcome of the Board Meeting pursuant to Regulation 30 and Regulation 33 of SEBI(Listing Obligation and Disclosure Requirements) Regulations, 2015 Outcome of Board meeting pursuant to Regulation 30 and Regulation 33 of SEBI(Listing Obligation and Disclosure Requirements), Regulations, 2015 (As Per BSE Announcement Dated on 14.02.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.